about
Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma.Targeting HSP60 by subcutaneous injections of jetPEI/HSP60-shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth.Seroclearance of hepatitis B surface antigen following hepatitis E exacerbation on chronic hepatitis E and B dual infection in a renal transplant recipient: a case report.Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot studyA novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenibDiabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort studyMaintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in patients with chronic hepatitis BDecreasing seroprevalence of anti-hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019
P50
Q45999534-F7B89E82-AC97-4409-89FC-DB186AE20C24Q52577689-32242BF8-9699-4203-AFA0-0DF72D18893DQ54265562-96B6C80C-A5AF-4681-9268-DE41CB3C777FQ59354950-4350F0BA-120D-4E73-843E-8D47F7E73D3DQ88767130-FB08E42D-CECD-4DA9-A050-3919FF718C72Q91438764-9B6CA73C-1860-4E4B-B48E-47537B156999Q92007823-3D55BF02-BA25-4212-B244-74089B19B3E5Q93007699-4B6AC920-6B42-40C8-B657-B71BC3ED1543
P50
description
researcher
@en
wetenschapper
@nl
name
Chau-Ting Yeh
@en
Chau-Ting Yeh
@nl
type
label
Chau-Ting Yeh
@en
Chau-Ting Yeh
@nl
prefLabel
Chau-Ting Yeh
@en
Chau-Ting Yeh
@nl
P31
P496
0000-0001-7376-275X